Salud financiera de hoja de balance de Bliss GVS Pharma
Salud financiera controles de criterios 6/6
Bliss GVS Pharma tiene un patrimonio de accionistas total de ₹10.5B y una deuda total de ₹832.9M, lo que sitúa su ratio deuda-patrimonio en 7.9%. Sus activos y pasivos totales son ₹12.8B y ₹2.3B respectivamente. El BAIT de Bliss GVS Pharma es de ₹1.2B, por lo que su ratio de cobertura de intereses es de -36.2. Tiene efectivo e inversiones a corto plazo que ascienden a ₹2.2B.
Información clave
7.9%
Ratio deuda-patrimonio
₹832.88m
Deuda
| Ratio de cobertura de intereses | -36.2x |
| Efectivo | ₹2.20b |
| Patrimonio | ₹10.48b |
| Total pasivo | ₹2.34b |
| Activos totales | ₹12.83b |
Actualizaciones recientes sobre salud financiera
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08Recent updates
Investors Don't See Light At End Of Bliss GVS Pharma Limited's (NSE:BLISSGVS) Tunnel
Nov 23Here's Why Bliss GVS Pharma (NSE:BLISSGVS) Has Caught The Eye Of Investors
Oct 26These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares
Aug 07Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now
Jul 19Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50
Jul 18Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Jul 04We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated
May 10Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹8.5B) de BLISSGVS superan a sus pasivos a corto plazo (₹1.9B).
Pasivo a largo plazo: Los activos a corto plazo de BLISSGVS (₹8.5B) superan a sus pasivos a largo plazo (₹418.8M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: BLISSGVS tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de BLISSGVS ha pasado de 12.9% a 7.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de BLISSGVS está bien cubierta por el flujo de caja operativo (126.1%).
Cobertura de intereses: BLISSGVS gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.